{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"ss-31-brain-fog","title":"SS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence Review","body":"## What's breaking down if you have Statin-associated cognitive effects\n\nStatin use carries a rare FDA-noted association with reversible cognitive symptoms such as memory loss or confusion in post-marketing reports. The mechanism is not fully established but may involve reduced cholesterol synthesis in the brain or effects on mitochondrial function in neurons. No large human trials link statins directly to permanent brain damage; symptoms are typically described as non-serious and resolve after discontinuation.\n\nIf mitochondrial oxidative stress or impaired energy production in brain cells contributes to your symptoms, that points to a repair pathway rather than simple symptom suppression.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about Statin-associated cognitive effects — what breaks down matters before any compound name.\n2. Therefore for you: If mitochondrial dysfunction in brain cells is part of your problem, SS-31 is discussed because it targets repair at the inner mitochondrial membrane — not because it masks symptoms.\n3. SS-31 binds cardiolipin, which can stabilize electron transport chain function and reduce reactive oxygen species leakage in preclinical models.\n4. If your cognitive effects trace to oxidative stress or synaptic loss in the hippocampus, this stabilization step precedes observed improvements in memory tasks in animal inflammation models.\n\n## How these fit together\n\nSingle-compound focus — SS-31 targets the mitochondrial layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile, but none are in scope here.\n\n## What the evidence actually shows\n\nPreclinical (mechanistic tier): In a 2019 mouse study, lipopolysaccharide (LPS) injection produced mitochondrial dysfunction, oxidative stress, synaptic loss, and impaired performance on Morris water maze and fear conditioning tests. SS-31 treatment restored some mitochondrial parameters and improved memory performance measures (preclinical). A 2021 rat study with aged animals and LPS showed similar cognitive rescue alongside reduced hippocampal inflammation (preclinical).\n\nHuman (human tier): No randomized controlled trials test SS-31 for statin-associated cognitive effects. Phase 1/2 and 2/3 trials in primary mitochondrial myopathy (36 participants) and Barth syndrome showed dose-dependent improvements in exercise capacity and some functional scores but did not measure cognition as primary endpoint (human). Alzheimer's Discovery Foundation review states no human data support cognitive benefits in dementia models (human tier: none available).\n\n## What scientists say\n\nReviews note that SS-31 improves mitochondrial and synaptic markers in rodent models of cognitive impairment but emphasize these effects remain unconfirmed in humans. Clinical trial focus remains on rare mitochondrial diseases rather than statin side effects.\n\n## What people say on Reddit\n\nAnecdotal tier: In r/cfs and r/covidlonghaulers threads, a few users report reduced brain fog and better energy after SS-31 use; others report no change or temporary worsening. Posts are self-selected and unverified (anecdotal).\n\n## What people say on X\n\nLimited public posts; no high-volume verified anecdotes specifically tying SS-31 to statin brain fog resolution (anecdotal tier: sparse).\n\n## What we do not know\n\nNo human data exist on SS-31 for statin-related cognitive symptoms. Long-term effects, optimal timing relative to statin use, and interaction with cholesterol pathways remain unstudied. Animal models use acute inflammation (LPS), which differs from chronic statin exposure.\n\n## Safety and limits\n\nSS-31 has completed multiple human trials with generally acceptable tolerability in mitochondrial disease populations. Individual responses vary; no compound replaces medical evaluation of statin use or cognitive symptoms. Evidence for this specific application is preclinical only.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/ss-31-brain-fog/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"FDA warning notes rare, reversible cognitive impairment reports with statins.","section":"What's breaking down if you have Statin-associated cognitive effects","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes baseline for condition without overstatement.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"2019 mouse LPS study: SS-31 improved mitochondrial function and memory task performance.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Core preclinical signal for mitochondrial-cognitive link.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"No human RCTs of SS-31 for statin cognitive effects.","section":"What we do not know","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Clarifies evidence gap for reader.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users report mixed brain fog changes with SS-31 in CFS contexts.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Separates anecdote from trial data.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"news","url":"https://www.lipid.org/lipid-spin/summer-2020/guest-editorial-statins-and-brain-fog-confusing-patients-prescribers-and-me","title":"Statins and Brain Fog editorial","quote":"There have been rare post-marketing reports of cognitive impairment... associated with statin use.","summary":"FDA warning text and context on reversibility.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:58:53.300Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"8481054eb241b98657ac6f1df0d559c6a65c563612504431af0522a0f5eef988"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6865061/","title":"Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice","quote":"Treatment with elamipretide significantly ameliorated LPS-induced learning and memory impairment during behavioral tests.","summary":"Mouse study showing cognitive rescue via mitochondrial targeting.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:58:53.300Z","link_status":"ok","quote_status":"verified","prev":"8481054eb241b98657ac6f1df0d559c6a65c563612504431af0522a0f5eef988","hash":"96b82bc8c7b3c85be88868d6a60c2a60c1fa99b308b9ba1cfc3680295d404b6b"},{"id":"s3","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/SS-31-Cognitive-Vitality-For-Researchers.pdf","title":"SS-31 Cognitive Vitality review","quote":"But these effects have not been confirmed in humans. ... None available.","summary":"Explicit statement of absent human cognitive trial data.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:58:53.300Z","link_status":"ok","quote_status":"unverified","prev":"96b82bc8c7b3c85be88868d6a60c2a60c1fa99b308b9ba1cfc3680295d404b6b","hash":"3505679aceb5aaf837e3906b72ce5d56c1f71a17df9318fde8c6f2fa72f1652f"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/cfs/comments/1j2upcm/my_experience_treating_my_mecfs_with/","title":"Reddit CFS SS-31 thread","quote":"SS-31 has been the single most effective treatment I have tried for improving energy. It has improved my cognitive function by 50%.","summary":"User anecdote on cognitive improvement.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:58:53.300Z","link_status":"ok","quote_status":"unverified","prev":"3505679aceb5aaf837e3906b72ce5d56c1f71a17df9318fde8c6f2fa72f1652f","hash":"a3d5997844f2a9879bb882615b4d11c2ed7c8d392daf68bf67311ea842702396"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:58:54.013Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"SS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Statin-associated cognitive effects\n\nStatin use carries a rare FDA-noted association with reversible cognitive symptoms such as memory loss or confusion in post-marketing reports. The mechanism is not fully established but may involve reduced cholesterol synthesis in the brain or effects on mitochondrial function in neurons. No large human trials link statins directly to permanent brain damage; symptoms are typically described as non-serious and resolve after discontinuation.\n\nIf mitochondrial oxidative stress or impaired energy production in brain cells contributes to your symptoms, that points to a repair pathway rather than simple symptom suppression.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about Statin-associated cognitive effects — what breaks down matters before any compound name.\n2. Therefore for you: If mitochondrial dysfunction in brain cells is part of your problem, SS-31 is discussed because it targets repair at the inner mitochondrial membrane — not because it masks symptoms.\n3. SS-31 binds cardiolipin, which can stabilize electron transport chain function and reduce reactive oxygen species leakage in preclinical models.\n4. If your cognitive effects trace to oxidative stress or synaptic loss in the hippocampus, this stabilization step precedes observed improvements in memory tasks in animal inflammation models.\n\n## How these fit together\n\nSingle-compound focus — SS-31 targets the mitochondrial layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile, but none are in scope here.\n\n## What the evidence actually shows\n\nPreclinical (mechanistic tier): In a 2019 mouse study, lipopolysaccharide (LPS) injection produced mitochondrial dysfunction, oxidative stress, synaptic loss, and impaired performance on Morris water maze and fear conditioning tests. SS-31 treatment restored some mitochondrial parameters and improved memory performance measures (preclinical). A 2021 rat study with aged animals and LPS showed similar cognitive rescue alongside reduced hippocampal inflammation (preclinical).\n\nHuman (human tier): No randomized controlled trials test SS-31 for statin-associated cognitive effects. Phase 1/2 and 2/3 trials in primary mitochondrial myopathy (36 participants) and Barth syndrome showed dose-dependent improvements in exercise capacity and some functional scores but did not measure cognition as primary endpoint (human). Alzheimer's Discovery Foundation review states no human data support cognitive benefits in dementia models (human tier: none available).\n\n## What scientists say\n\nReviews note that SS-31 improves mitochondrial and synaptic markers in rodent models of cognitive impairment but emphasize these effects remain unconfirmed in humans. Clinical trial focus remains on rare mitochondrial diseases rather than statin side effects.\n\n## What people say on Reddit\n\nAnecdotal tier: In r/cfs and r/covidlonghaulers threads, a few users report reduced brain fog and better energy after SS-31 use; others report no change or temporary worsening. Posts are self-selected and unverified (anecdotal).\n\n## What people say on X\n\nLimited public posts; no high-volume verified anecdotes specifically tying SS-31 to statin brain fog resolution (anecdotal tier: sparse).\n\n## What we do not know\n\nNo human data exist on SS-31 for statin-related cognitive symptoms. Long-term effects, optimal timing relative to statin use, and interaction with cholesterol pathways remain unstudied. Animal models use acute inflammation (LPS), which differs from chronic statin exposure.\n\n## Safety and limits\n\nSS-31 has completed multiple human trials with generally acceptable tolerability in mitochondrial disease populations. Individual responses vary; no compound replaces medical evaluation of statin use or cognitive symptoms. Evidence for this specific application is preclinical only.","claims":[{"id":"c1","text":"FDA warning notes rare, reversible cognitive impairment reports with statins.","section":"What's breaking down if you have Statin-associated cognitive effects","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes baseline for condition without overstatement.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"2019 mouse LPS study: SS-31 improved mitochondrial function and memory task performance.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Core preclinical signal for mitochondrial-cognitive link.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"No human RCTs of SS-31 for statin cognitive effects.","section":"What we do not know","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Clarifies evidence gap for reader.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users report mixed brain fog changes with SS-31 in CFS contexts.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Separates anecdote from trial data.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"news","url":"https://www.lipid.org/lipid-spin/summer-2020/guest-editorial-statins-and-brain-fog-confusing-patients-prescribers-and-me","title":"Statins and Brain Fog editorial","quote":"There have been rare post-marketing reports of cognitive impairment... associated with statin use.","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6865061/","title":"Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice","quote":"Treatment with elamipretide significantly ameliorated LPS-induced learning and memory impairment during behavioral tests.","link_status":"ok","quote_status":"verified"},{"id":"s3","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/SS-31-Cognitive-Vitality-For-Researchers.pdf","title":"SS-31 Cognitive Vitality review","quote":"But these effects have not been confirmed in humans. ... None available.","link_status":"ok","quote_status":"unverified"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/cfs/comments/1j2upcm/my_experience_treating_my_mecfs_with/","title":"Reddit CFS SS-31 thread","quote":"SS-31 has been the single most effective treatment I have tried for improving energy. It has improved my cognitive function by 50%.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":13976,"tokens_out":2411,"cost":0.0234975,"prev_hash":"genesis","hash":"dbae8ba94575f5cb30c8e80a6c664d0ebed5395b55763009da3c4bf0d1bc7072"}],"provenance":[{"ts":"2026-06-29T23:58:54.013Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Brain Fog\nSlug: ss-31-brain-fog\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Statin-associated cognitive effects\",\"condition_key\":\"statin-brain-fog\",\"primary_peptide\":\"ss-31\",\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Statin-associated cognitive effects\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"You are reading about **Statin-associated cognitive effects** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Statin-associated cognitive effects** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **SS-31 (Elamipretide)** → mitochondrial\",\"","response":"{\n  \"slug\": \"ss-31-brain-fog\",\n  \"title\": \"SS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence Review\",\n  \"body\": \"## What's breaking down if you have Statin-associated cognitive effects\\n\\nStatin use carries a rare FDA-noted association with reversible cognitive symptoms such as memory loss or confusion in post-marketing reports. The mechanism is not fully established but may involve reduced cholesterol synthesis in the brain or effects on mitochondrial function in neurons. No large human trials link statins directly to permanent brain damage; symptoms are typically described as non-serious and resolve after discontinuation.\\n\\nIf mitochondrial oxidative stress or impaired energy production in brain cells contributes to your symptoms, that points to a repair pathway rather than simple symptom suppression.\\n\\n## Why SS-31 (Elamipretide) might help you\\n\\n1. You are reading about Statin-associated cognitive effects — what breaks down matters before any compound name.\\n2. Therefore for you: If mitochondrial dysfunction in brain cells is part of your problem, SS-31 is discussed because it targets repair at the inner mitochondrial membrane — not because it masks symptoms.\\n3. SS-31 binds cardiolipin, which can stabilize electron transport chain function and reduce reactive oxygen species leakage in preclinical models.\\n4. If your cognitive effects trace to oxidative stress or synaptic loss in the hippocampus, this stabilization step precedes observed improvements in memory tasks in animal inflammation models.\\n\\n## How these fit together\\n\\nSingle-compound focus — SS-31 targets the mitochondrial layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile, but none are in scope here.\\n\\n## What the evidence actually shows\\n\\nPreclinical (mechanistic tier): In a 2019 mouse study, lipopolysaccharide (LPS) injection produced mitochondrial dysfunction, oxidative stress, synaptic loss, ","tokens_in":13976,"tokens_out":2411,"cost":0,"prev":"genesis","hash":"56f89b04e54ddfddc5d87b142ef8d051951fb5613de8a906121565907d228c4c"},{"ts":"2026-07-17T02:42:01.395Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-brain-fog","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"56f89b04e54ddfddc5d87b142ef8d051951fb5613de8a906121565907d228c4c","hash":"bb59b259ec00e13b0024ef9b43ad72e3dd279485a7fdb3c24540abe9d05fdef3"}],"energy":{"passes":2,"tokens_in":13976,"tokens_out":2411,"tokens_total":16387,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"bb59b259ec00e13b0024ef9b43ad72e3dd279485a7fdb3c24540abe9d05fdef3"},"posted_at":"2026-06-29T21:33:20.391Z","created_at":"2026-06-29T21:33:20.391Z","updated_at":"2026-07-17T02:42:01.395Z","machine":{"shape":"article.machine/v1","slug":"ss-31-brain-fog","kind":"article","read":{"human":"https://miscsubjects.com/a/ss-31-brain-fog","json":"https://miscsubjects.com/api/articles/ss-31-brain-fog","bundle":"https://miscsubjects.com/api/articles/ss-31-brain-fog/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":4,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/ss-31-brain-fog/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=ss-31-brain-fog","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-brain-fog\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-brain-fog\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/ss-31-brain-fog/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"ss-31-brain-fog\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/ss-31-brain-fog | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/ss-31-brain-fog","json":"/api/articles/ss-31-brain-fog","markdown":"/api/articles/ss-31-brain-fog/bundle?format=markdown","skill":"/api/articles/ss-31-brain-fog/skill","topology":"/api/articles/ss-31-brain-fog/topology","versions":"/api/articles/ss-31-brain-fog/revisions","invocations":"/api/articles/ss-31-brain-fog/invocations"},"editorial_review":null,"editorial_audit":{"slug":"ss-31-brain-fog","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"d6827fa4ec02f892d86c993d8a10b0cb1805fa15d586bfe045d8983039e0d0f3","object":{"object_type":"article-object","identity":{"id":"article:ss-31-brain-fog","slug":"ss-31-brain-fog","title":"SS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence Review"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/ss-31-brain-fog","role":"explain","audience":"human"},"skill":{"route":"/api/articles/ss-31-brain-fog/skill","role":"direct behavior","audience":"model","content":"---\nname: ss-31-brain-fog\ndescription: Apply the SS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# SS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence Review\n\nThis Skill is the behavioral expression of [the canonical article](/a/ss-31-brain-fog). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/ss-31-brain-fog.\n- Read claims and relationships at /api/articles/ss-31-brain-fog/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down if you have Statin-associated cognitive effects Statin use carries a rare FDA-noted association with reversible cognitive symptoms such as memory loss or confusion in post-marketing reports. The mechanism is not fully e\n\n## Representations\n\n- Human: /a/ss-31-brain-fog\n- JSON: /api/articles/ss-31-brain-fog\n- Relationships: /api/articles/ss-31-brain-fog/topology\n- History: /api/articles/ss-31-brain-fog/revisions\n"},"json":{"route":"/api/articles/ss-31-brain-fog","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/ss-31-brain-fog/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","ss","31","brain","fog"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/ss-31-brain-fog/invocations?status=success","failure_events":"/api/articles/ss-31-brain-fog/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"ss-31-brain-fog","title":"SS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence Review","body":"## What's breaking down if you have Statin-associated cognitive effects\n\nStatin use carries a rare FDA-noted association with reversible cognitive symptoms such as memory loss or confusion in post-marketing reports. The mechanism is not fully established but may involve reduced cholesterol synthesis in the brain or effects on mitochondrial function in neurons. No large human trials link statins directly to permanent brain damage; symptoms are typically described as non-serious and resolve after discontinuation.\n\nIf mitochondrial oxidative stress or impaired energy production in brain cells contributes to your symptoms, that points to a repair pathway rather than simple symptom suppression.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about Statin-associated cognitive effects — what breaks down matters before any compound name.\n2. Therefore for you: If mitochondrial dysfunction in brain cells is part of your problem, SS-31 is discussed because it targets repair at the inner mitochondrial membrane — not because it masks symptoms.\n3. SS-31 binds cardiolipin, which can stabilize electron transport chain function and reduce reactive oxygen species leakage in preclinical models.\n4. If your cognitive effects trace to oxidative stress or synaptic loss in the hippocampus, this stabilization step precedes observed improvements in memory tasks in animal inflammation models.\n\n## How these fit together\n\nSingle-compound focus — SS-31 targets the mitochondrial layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile, but none are in scope here.\n\n## What the evidence actually shows\n\nPreclinical (mechanistic tier): In a 2019 mouse study, lipopolysaccharide (LPS) injection produced mitochondrial dysfunction, oxidative stress, synaptic loss, and impaired performance on Morris water maze and fear conditioning tests. SS-31 treatment restored some mitochondrial parameters and improved memory performance measures (preclinical). A 2021 rat study with aged animals and LPS showed similar cognitive rescue alongside reduced hippocampal inflammation (preclinical).\n\nHuman (human tier): No randomized controlled trials test SS-31 for statin-associated cognitive effects. Phase 1/2 and 2/3 trials in primary mitochondrial myopathy (36 participants) and Barth syndrome showed dose-dependent improvements in exercise capacity and some functional scores but did not measure cognition as primary endpoint (human). Alzheimer's Discovery Foundation review states no human data support cognitive benefits in dementia models (human tier: none available).\n\n## What scientists say\n\nReviews note that SS-31 improves mitochondrial and synaptic markers in rodent models of cognitive impairment but emphasize these effects remain unconfirmed in humans. Clinical trial focus remains on rare mitochondrial diseases rather than statin side effects.\n\n## What people say on Reddit\n\nAnecdotal tier: In r/cfs and r/covidlonghaulers threads, a few users report reduced brain fog and better energy after SS-31 use; others report no change or temporary worsening. Posts are self-selected and unverified (anecdotal).\n\n## What people say on X\n\nLimited public posts; no high-volume verified anecdotes specifically tying SS-31 to statin brain fog resolution (anecdotal tier: sparse).\n\n## What we do not know\n\nNo human data exist on SS-31 for statin-related cognitive symptoms. Long-term effects, optimal timing relative to statin use, and interaction with cholesterol pathways remain unstudied. Animal models use acute inflammation (LPS), which differs from chronic statin exposure.\n\n## Safety and limits\n\nSS-31 has completed multiple human trials with generally acceptable tolerability in mitochondrial disease populations. Individual responses vary; no compound replaces medical evaluation of statin use or cognitive symptoms. Evidence for this specific application is preclinical only.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/ss-31-brain-fog/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"FDA warning notes rare, reversible cognitive impairment reports with statins.","section":"What's breaking down if you have Statin-associated cognitive effects","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes baseline for condition without overstatement.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"2019 mouse LPS study: SS-31 improved mitochondrial function and memory task performance.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Core preclinical signal for mitochondrial-cognitive link.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"No human RCTs of SS-31 for statin cognitive effects.","section":"What we do not know","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Clarifies evidence gap for reader.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users report mixed brain fog changes with SS-31 in CFS contexts.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Separates anecdote from trial data.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"news","url":"https://www.lipid.org/lipid-spin/summer-2020/guest-editorial-statins-and-brain-fog-confusing-patients-prescribers-and-me","title":"Statins and Brain Fog editorial","quote":"There have been rare post-marketing reports of cognitive impairment... associated with statin use.","summary":"FDA warning text and context on reversibility.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:58:53.300Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"8481054eb241b98657ac6f1df0d559c6a65c563612504431af0522a0f5eef988"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6865061/","title":"Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice","quote":"Treatment with elamipretide significantly ameliorated LPS-induced learning and memory impairment during behavioral tests.","summary":"Mouse study showing cognitive rescue via mitochondrial targeting.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:58:53.300Z","link_status":"ok","quote_status":"verified","prev":"8481054eb241b98657ac6f1df0d559c6a65c563612504431af0522a0f5eef988","hash":"96b82bc8c7b3c85be88868d6a60c2a60c1fa99b308b9ba1cfc3680295d404b6b"},{"id":"s3","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/SS-31-Cognitive-Vitality-For-Researchers.pdf","title":"SS-31 Cognitive Vitality review","quote":"But these effects have not been confirmed in humans. ... None available.","summary":"Explicit statement of absent human cognitive trial data.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:58:53.300Z","link_status":"ok","quote_status":"unverified","prev":"96b82bc8c7b3c85be88868d6a60c2a60c1fa99b308b9ba1cfc3680295d404b6b","hash":"3505679aceb5aaf837e3906b72ce5d56c1f71a17df9318fde8c6f2fa72f1652f"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/cfs/comments/1j2upcm/my_experience_treating_my_mecfs_with/","title":"Reddit CFS SS-31 thread","quote":"SS-31 has been the single most effective treatment I have tried for improving energy. It has improved my cognitive function by 50%.","summary":"User anecdote on cognitive improvement.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:58:53.300Z","link_status":"ok","quote_status":"unverified","prev":"3505679aceb5aaf837e3906b72ce5d56c1f71a17df9318fde8c6f2fa72f1652f","hash":"a3d5997844f2a9879bb882615b4d11c2ed7c8d392daf68bf67311ea842702396"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:58:54.013Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"SS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Statin-associated cognitive effects\n\nStatin use carries a rare FDA-noted association with reversible cognitive symptoms such as memory loss or confusion in post-marketing reports. The mechanism is not fully established but may involve reduced cholesterol synthesis in the brain or effects on mitochondrial function in neurons. No large human trials link statins directly to permanent brain damage; symptoms are typically described as non-serious and resolve after discontinuation.\n\nIf mitochondrial oxidative stress or impaired energy production in brain cells contributes to your symptoms, that points to a repair pathway rather than simple symptom suppression.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about Statin-associated cognitive effects — what breaks down matters before any compound name.\n2. Therefore for you: If mitochondrial dysfunction in brain cells is part of your problem, SS-31 is discussed because it targets repair at the inner mitochondrial membrane — not because it masks symptoms.\n3. SS-31 binds cardiolipin, which can stabilize electron transport chain function and reduce reactive oxygen species leakage in preclinical models.\n4. If your cognitive effects trace to oxidative stress or synaptic loss in the hippocampus, this stabilization step precedes observed improvements in memory tasks in animal inflammation models.\n\n## How these fit together\n\nSingle-compound focus — SS-31 targets the mitochondrial layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile, but none are in scope here.\n\n## What the evidence actually shows\n\nPreclinical (mechanistic tier): In a 2019 mouse study, lipopolysaccharide (LPS) injection produced mitochondrial dysfunction, oxidative stress, synaptic loss, and impaired performance on Morris water maze and fear conditioning tests. SS-31 treatment restored some mitochondrial parameters and improved memory performance measures (preclinical). A 2021 rat study with aged animals and LPS showed similar cognitive rescue alongside reduced hippocampal inflammation (preclinical).\n\nHuman (human tier): No randomized controlled trials test SS-31 for statin-associated cognitive effects. Phase 1/2 and 2/3 trials in primary mitochondrial myopathy (36 participants) and Barth syndrome showed dose-dependent improvements in exercise capacity and some functional scores but did not measure cognition as primary endpoint (human). Alzheimer's Discovery Foundation review states no human data support cognitive benefits in dementia models (human tier: none available).\n\n## What scientists say\n\nReviews note that SS-31 improves mitochondrial and synaptic markers in rodent models of cognitive impairment but emphasize these effects remain unconfirmed in humans. Clinical trial focus remains on rare mitochondrial diseases rather than statin side effects.\n\n## What people say on Reddit\n\nAnecdotal tier: In r/cfs and r/covidlonghaulers threads, a few users report reduced brain fog and better energy after SS-31 use; others report no change or temporary worsening. Posts are self-selected and unverified (anecdotal).\n\n## What people say on X\n\nLimited public posts; no high-volume verified anecdotes specifically tying SS-31 to statin brain fog resolution (anecdotal tier: sparse).\n\n## What we do not know\n\nNo human data exist on SS-31 for statin-related cognitive symptoms. Long-term effects, optimal timing relative to statin use, and interaction with cholesterol pathways remain unstudied. Animal models use acute inflammation (LPS), which differs from chronic statin exposure.\n\n## Safety and limits\n\nSS-31 has completed multiple human trials with generally acceptable tolerability in mitochondrial disease populations. Individual responses vary; no compound replaces medical evaluation of statin use or cognitive symptoms. Evidence for this specific application is preclinical only.","claims":[{"id":"c1","text":"FDA warning notes rare, reversible cognitive impairment reports with statins.","section":"What's breaking down if you have Statin-associated cognitive effects","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes baseline for condition without overstatement.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"2019 mouse LPS study: SS-31 improved mitochondrial function and memory task performance.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Core preclinical signal for mitochondrial-cognitive link.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"No human RCTs of SS-31 for statin cognitive effects.","section":"What we do not know","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Clarifies evidence gap for reader.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users report mixed brain fog changes with SS-31 in CFS contexts.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Separates anecdote from trial data.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:58:53.624Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"news","url":"https://www.lipid.org/lipid-spin/summer-2020/guest-editorial-statins-and-brain-fog-confusing-patients-prescribers-and-me","title":"Statins and Brain Fog editorial","quote":"There have been rare post-marketing reports of cognitive impairment... associated with statin use.","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6865061/","title":"Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice","quote":"Treatment with elamipretide significantly ameliorated LPS-induced learning and memory impairment during behavioral tests.","link_status":"ok","quote_status":"verified"},{"id":"s3","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/SS-31-Cognitive-Vitality-For-Researchers.pdf","title":"SS-31 Cognitive Vitality review","quote":"But these effects have not been confirmed in humans. ... None available.","link_status":"ok","quote_status":"unverified"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/cfs/comments/1j2upcm/my_experience_treating_my_mecfs_with/","title":"Reddit CFS SS-31 thread","quote":"SS-31 has been the single most effective treatment I have tried for improving energy. It has improved my cognitive function by 50%.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":13976,"tokens_out":2411,"cost":0.0234975,"prev_hash":"genesis","hash":"dbae8ba94575f5cb30c8e80a6c664d0ebed5395b55763009da3c4bf0d1bc7072"}],"provenance":[{"ts":"2026-06-29T23:58:54.013Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Brain Fog\nSlug: ss-31-brain-fog\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Statin-associated cognitive effects\",\"condition_key\":\"statin-brain-fog\",\"primary_peptide\":\"ss-31\",\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Statin-associated cognitive effects\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"You are reading about **Statin-associated cognitive effects** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Statin-associated cognitive effects** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **SS-31 (Elamipretide)** → mitochondrial\",\"","response":"{\n  \"slug\": \"ss-31-brain-fog\",\n  \"title\": \"SS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence Review\",\n  \"body\": \"## What's breaking down if you have Statin-associated cognitive effects\\n\\nStatin use carries a rare FDA-noted association with reversible cognitive symptoms such as memory loss or confusion in post-marketing reports. The mechanism is not fully established but may involve reduced cholesterol synthesis in the brain or effects on mitochondrial function in neurons. No large human trials link statins directly to permanent brain damage; symptoms are typically described as non-serious and resolve after discontinuation.\\n\\nIf mitochondrial oxidative stress or impaired energy production in brain cells contributes to your symptoms, that points to a repair pathway rather than simple symptom suppression.\\n\\n## Why SS-31 (Elamipretide) might help you\\n\\n1. You are reading about Statin-associated cognitive effects — what breaks down matters before any compound name.\\n2. Therefore for you: If mitochondrial dysfunction in brain cells is part of your problem, SS-31 is discussed because it targets repair at the inner mitochondrial membrane — not because it masks symptoms.\\n3. SS-31 binds cardiolipin, which can stabilize electron transport chain function and reduce reactive oxygen species leakage in preclinical models.\\n4. If your cognitive effects trace to oxidative stress or synaptic loss in the hippocampus, this stabilization step precedes observed improvements in memory tasks in animal inflammation models.\\n\\n## How these fit together\\n\\nSingle-compound focus — SS-31 targets the mitochondrial layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile, but none are in scope here.\\n\\n## What the evidence actually shows\\n\\nPreclinical (mechanistic tier): In a 2019 mouse study, lipopolysaccharide (LPS) injection produced mitochondrial dysfunction, oxidative stress, synaptic loss, ","tokens_in":13976,"tokens_out":2411,"cost":0,"prev":"genesis","hash":"56f89b04e54ddfddc5d87b142ef8d051951fb5613de8a906121565907d228c4c"},{"ts":"2026-07-17T02:42:01.395Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-brain-fog","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"56f89b04e54ddfddc5d87b142ef8d051951fb5613de8a906121565907d228c4c","hash":"bb59b259ec00e13b0024ef9b43ad72e3dd279485a7fdb3c24540abe9d05fdef3"}],"energy":{"passes":2,"tokens_in":13976,"tokens_out":2411,"tokens_total":16387,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"bb59b259ec00e13b0024ef9b43ad72e3dd279485a7fdb3c24540abe9d05fdef3"},"posted_at":"2026-06-29T21:33:20.391Z","created_at":"2026-06-29T21:33:20.391Z","updated_at":"2026-07-17T02:42:01.395Z","machine":{"shape":"article.machine/v1","slug":"ss-31-brain-fog","kind":"article","read":{"human":"https://miscsubjects.com/a/ss-31-brain-fog","json":"https://miscsubjects.com/api/articles/ss-31-brain-fog","bundle":"https://miscsubjects.com/api/articles/ss-31-brain-fog/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":4,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/ss-31-brain-fog/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=ss-31-brain-fog","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-brain-fog\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-brain-fog\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/ss-31-brain-fog/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"ss-31-brain-fog\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/ss-31-brain-fog | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/ss-31-brain-fog","json":"/api/articles/ss-31-brain-fog","markdown":"/api/articles/ss-31-brain-fog/bundle?format=markdown","skill":"/api/articles/ss-31-brain-fog/skill","topology":"/api/articles/ss-31-brain-fog/topology","versions":"/api/articles/ss-31-brain-fog/revisions","invocations":"/api/articles/ss-31-brain-fog/invocations"},"editorial_review":null,"editorial_audit":{"slug":"ss-31-brain-fog","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"d6827fa4ec02f892d86c993d8a10b0cb1805fa15d586bfe045d8983039e0d0f3"}}}